Definition:Incurred but not reported analysis (IBNR analysis)

📊 Incurred but not reported analysis (IBNR analysis) is the actuarial process of estimating the value of insurance claims that have already occurred but have not yet been reported to the carrier. Every insurer carries a population of latent claims — events that took place before the reporting date but remain invisible because policyholders have not yet filed notice, or because the loss has not yet been discovered. IBNR analysis applies statistical and actuarial techniques to quantify these hidden liabilities, producing an estimate that feeds directly into the loss reserves recorded on an insurer's balance sheet. The practice is fundamental across all major insurance markets, though the specific methodologies, regulatory expectations, and disclosure requirements differ under frameworks such as US GAAP, IFRS 17, Solvency II, and China's C-ROSS.

⚙️ Actuaries performing IBNR analysis draw on a toolkit of well-established methods — chain-ladder, Bornhuetter-Ferguson, frequency-severity models, and Cape Cod approaches among them — often blending several to triangulate a best estimate. The analysis begins with organizing historical claims data into loss development triangles, which track how reported and paid losses evolve over successive periods. By studying these patterns, actuaries project the remaining development on known claims and estimate the volume of claims not yet in the system. Long-tail lines such as general liability, workers' compensation, and medical malpractice demand especially careful IBNR analysis because losses may emerge years or even decades after the policy period. Shorter-tail lines like property or motor physical damage still require IBNR estimation, though the uncertainty window is narrower.

💡 Accurate IBNR analysis is the linchpin of financial credibility for any insurance organization. Understating IBNR leads to reserve deficiencies that can erode surplus, trigger regulatory intervention, and surprise investors with adverse reserve development. Overstating it unnecessarily ties up capital that could otherwise support growth or be returned to shareholders. During M&A transactions, acquirers scrutinize the target's IBNR methodology as part of actuarial due diligence, since any misjudgment flows directly into the purchase price and post-closing exposure. Regulators worldwide — from the NAIC in the United States to the PRA in the United Kingdom and the MAS in Singapore — require that insurers maintain adequate IBNR provisions and, in many cases, that an independent actuarial opinion confirm their reasonableness.

Related concepts: